Detalhe da pesquisa
1.
Author Correction: At the end of the beginning: immunotherapies as living drugs.
Nat Immunol
; 20(10): 1405, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388150
2.
At the end of the beginning: immunotherapies as living drugs.
Nat Immunol
; 20(8): 955-962, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308544
3.
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation.
Br J Clin Pharmacol
; 85(9): 1874-1877, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31290181
4.
17α-Ethynylestradiol-3-sulfate treatment of severe blood loss in rats.
J Surg Res
; 193(1): 355-60, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085704
5.
Physiologically-based pharmacokinetics in drug development and regulatory science.
Annu Rev Pharmacol Toxicol
; 51: 45-73, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20854171
6.
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA.
AAPS J
; 26(2): 28, 2024 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38413548
7.
Comparing a Bayesian Approach (BEST) with the Two One-Sided t-Tests (TOSTs) for Bioequivalence Studies.
AAPS J
; 24(5): 97, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050426
8.
Quantitative clinical pharmacology is transforming drug regulation.
J Pharmacokinet Pharmacodyn
; 37(6): 617-28, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20978827
9.
Scientific considerations for global drug development.
Sci Transl Med
; 12(554)2020 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727913
10.
Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.
Physiol Rep
; 6(5)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29488355
11.
Current issues relating to drug safety especially with regard to the use of biomarkers: a meeting report and progress update.
Eur J Pharm Sci
; 30(2): 107-12, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17196378
12.
Probability of Success: A Crucial Concept to Inform Decision Making in Pharmaceutical Research and Development.
Clin Pharmacol Ther
; 111(5): 1001-1003, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34951934
13.
Poor medication adherence in clinical trials: consequences and solutions.
Nat Rev Drug Discov
; 16(3): 149-150, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28154411
14.
Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013.
Drug Des Devel Ther
; 10: 4005-4016, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27994442
15.
Farewell to our Wonderful Friend and Colleague, J. Richard (Dick) Crout (1929-2020).
Clin Pharmacol Ther
; 109(6): 1384-1387, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33111972
16.
Population pharmacokinetic analysis and simulation of the time-concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis.
J Clin Pharmacol
; 45(3): 246-56, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15703360
17.
Sir Alasdair Breckenridge 1937-2019. A Celebratory Tribute.
Clin Pharmacol Ther
; 108(1): 22-25, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279311
18.
Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis.
Clin Pharmacol Ther
; 73(4): 348-65, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12709725
19.
Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 29-30, 2002).
AAPS PharmSci
; 6(1): E6, 2004 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-15198507
20.
Bayesian Approach to Establish Bioequivalence: Why and How?
Clin Pharmacol Ther
; 105(2): 301-303, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666630